Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor versus clopidogrel after CABG for acute coronary syndrome
ACTRN12613001362785Phase 4Terminated
- Sponsor
- Waikato District Health Board
- Start
- Aug 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in acute coronary syndrome (ACS) and coronary arteriosclerosis comparing Aspirin + ticagrelor with Aspirin + clopidogrel (2 arms). Primary endpoint: Coronary graft patency. Started Aug 2014; status: terminated.
02
Drugs
ticagrelorclopidogrelaspirin
03
Conditions
acute coronary syndrome (ACS)coronary arteriosclerosis
Beyond the preview
Go deeper on ACTRN12613001362785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001362785.